|
시장보고서
상품코드
2075214
세포 건강 스크리닝 검사 시장 : 검사 유형별, 검체 유형별, 제품 유형, 기술별, 최종사용자별, 지역별Cellular Health Screening Test Market, By Test Type, By Sample Type, By Product Type, By Technology, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세포 건강 스크리닝 검사 시장은 2026년에 41억 4,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 95억 5,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 41억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.70% | 2033년 시장 규모 예측 : | 95억 5,000만 달러 |
세포 건강 스크리닝 검사는 개인의 전반적인 건강 상태 및 웰빙에 관한 정보를 제공하는 여러 가지 지표에 대한 혈액 검사입니다. 이 검사를 통해 심장, 간, 신장 등 주요 신체 기관과 관련된 24가지 바이오마커를 분석합니다. 이러한 바이오마커는 영양 부족, 만성 염증, 대사 불균형 및 기타 건강 문제를 시사합니다. 이 보고서에서는 세포 수준에서 건강에 영향을 미치는 주요 지표에 초점을 맞추고 있습니다. 이러한 상세한 정보를 활용함으로써, 개인은 의료 전문가와 협력하여 부족한 영양소를 보충하고, 전반적인 건강과 웰빙을 향상시키기 위해 목표에 맞춘 식단 및 생활 습관 개선을 실천할 수 있습니다.
시장 역학 :
세포 건강 선별 검사 시장의 성장을 이끄는 주요 요인 중 하나는 예방 의료의 중요성에 대한 사람들의 인식이 높아지고 있다는 점입니다. 질병을 조기에 발견하면 건강상의 예후가 크게 개선된다는 것이 알려져 있습니다. 전 세계 세포 건강 선별 검사 시장은 고령 인구 증가, 만성질환 유병률 상승, 예방 의료에 대한 의식의 향상, 진단 기술의 발전, 그리고 개발도상국의 가처분 소득 증가에 힘입어 성장하고 있습니다. 그러나 오랫동안 사람들은 잠재적인 문제에 대해 정기적으로 검진을 받는 것보다 증상 완화에 의존하는 경향이 더 강했습니다. 최근 들어 다양한 보건 기관과 정부 기관에서 생활 습관 개선과 증상이 나타나기 전의 일반적인 질환에 대한 정기 건강 검진의 중요성을 강조하고 있습니다. 그러나 엄격한 규제 정책, 불충분한 보험 적용 범위, 그리고 높은 검사 비용으로 인해 시장 성장이 제한되고 있습니다. 이 시장은 미개발 신흥 시장, 원격의료 및 재택 의료에 대한 관심 증가, 그리고 신속하고 간편한 선별 검사에 대한 수요 증가로 인해 각 기업에 비즈니스 기회를 제공하고 있습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문에서 잠재적인 매출 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 세포 건강 검진 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 세포 건강 선별 검사 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 세포 건강 선별 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 세포 건강 스크리닝 검사 시장 : 테스트 유형별, 2021-2033년
제5장 세계의 세포 건강 스크리닝 검사 시장 : 샘플 유형별, 2021-2033년
제6장 세계의 세포 건강 스크리닝 검사 시장 : 제품 유형별, 2021-2033년
제7장 세계의 세포 건강 스크리닝 검사 시장 : 기술별, 2021-2033년
제8장 세계의 세포 건강 스크리닝 검사 시장 : 최종사용자별, 2021-2033년
제9장 세계의 세포 건강 스크리닝 검사 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.07Cellular Health Screening Test Market is estimated to be valued at USD 4.14 Bn in 2026 and is expected to reach USD 9.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.14 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.70% | 2033 Value Projection: | USD 9.55 Bn |
Cellular health screening test is a multi-marker blood test that provides information about an individual's overall health and wellness. It analyzes 24 biomarkers related to key body systems like heart, liver, kidneys, and others. These biomarkers indicate nutritional deficiencies, chronic inflammation, imbalanced metabolism, and other health issues. The report highlights key parameters that impact health on a cellular level. Using this detailed insight, individuals can work with their healthcare provider to address any deficiencies and make targeted dietary or lifestyle changes to improve overall health and wellness.
Market Dynamics:
One of the major drivers for the growth of the cellular health screening test market is the increasing awareness among people about the importance of preventive healthcare. Early detection of diseases has been known to improve health outcomes significantly. The global cellular health screening test market is driven by the growing geriatric population, rising prevalence of chronic diseases, increasing awareness about preventive healthcare, technological advancements in diagnostic techniques, and rising disposable income in developing countries. However, for a long time, people relied more on symptomatic treatment rather than getting screened regularly for potential issues. Off late, various health organizations and government bodies have been spreading the message of making lifestyle changes and undergoing routine medical checkups for common ailments even before symptoms appear. However, strict regulatory policies, insufficient insurance coverage, and high cost of tests limit the market growth. The market provides opportunities for players due to untapped emerging markets, growing focus on telehealth and home healthcare, and increasing demand for quick and easy screening tests.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cellular health screening test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Genova Diagnostics, Cell Science Systems, Life Length, Repeat Diagnostics, Titianovo, DNA Labs India, Segterra, Telomere Diagnostics, Spectracell Laboratories, Zimetry LLC, Immundiagnostik AG, Cleveland HeartLab, Inc., DNA Diagnostics Center, Immuno Diagnostics, Cell Science Systems Corporation, Life Length S.L., Repeat Diagnostics Inc., SpectraCell Laboratories, Telomere Diagnostics, Bloom Diagnostics, Kindbody, GRAIL, Inc, Atomo Diagnostics, OmegaQuant, Allara, and C2N Diagnostics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cellular health screening test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cellular health screening test market
Global Cellular Health Screening Test Market Detailed Segmentation:
- By Test Type (Revenue, USD Bn, 2021 - 2033)
- Telomere Tests
- Oxidative Stress Tests
- Inflammation Tests
- Heavy Metals Tests
- Vitamin D Tests
- Hormones Tests
- Others
- By Sample Type (Revenue, USD Bn, 2021 - 2033)
- Blood
- Saliva
- Urine
- Others
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Consumables
- Instruments
- Services
- By Technology (Revenue, USD Bn, 2021 - 2033)
- PCR
- Flow cytometry
- ELISA
- LC-MS
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Laboratories
- Research Institutes
- Homecare Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profile:
- Genova Diagnostics
- Cell Science Systems
- Life Length
- Repeat Diagnostics
- Titianovo
- DNA Labs India
- Segterra
- Telomere Diagnostics
- Spectracell Laboratories
- Zimetry LLC
- Immundiagnostik AG
- Cleveland HeartLab, Inc.
- DNA Diagnostics Center
- Immuno Diagnostics
- Cell Science Systems Corporation
- Life Length S.L.
- Repeat Diagnostics Inc.
- SpectraCell Laboratories
- Telomere Diagnostics
- Bloom Diagnostics
- Kindbody
- GRAIL, Inc
- Atomo Diagnostics
- OmegaQuant
- Allara
- C2N Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Test Type
- Market Snippet, By Sample Type
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Sample Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing Investments in Pharmaceutical R&D
- Availability of Alternative Technologies
- Surging Demand from Clinical Diagnostics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Cellular Health Screening Market, By Test Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Telomere Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Oxidative Stress Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Inflammation Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Heavy Metals Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Vitamin D Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hormones Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Cellular Health Screening Market, By Sample Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Cellular Health Screening Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Cellular Health Screening Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Flow cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- LC-MS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Cellular Health Screening Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Global Cellular Health Screening Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2028
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Genova Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Science Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Life Length
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Repeat Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Titianovo
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DNA Labs India
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Segterra
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Telomere Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Spectracell Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zimetry LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Immundiagnostik AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cleveland HeartLab, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cleveland HeartLab, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DNA Diagnostics Center
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Immuno Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cell Science Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Life Length S.L.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Repeat Diagnostics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SpectraCell Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Telomere Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bloom Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kindbody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GRAIL, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Atomo Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OmegaQuant
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Allara
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ca,,N Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
